BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,096,000 | +289.0% | 6,859,000 | +323.9% | 0.06% | +323.1% |
| Q2 2019 | $1,824,000 | +9.4% | 1,618,000 | +10.7% | 0.01% | -7.1% |
| Q1 2019 | $1,668,000 | +3968.3% | 1,462,000 | +4077.1% | 0.01% | – |
| Q2 2018 | $41,000 | -98.0% | 35,000 | -98.0% | 0.00% | -100.0% |
| Q1 2017 | $2,098,000 | -30.8% | 1,768,000 | -26.8% | 0.02% | 0.0% |
| Q3 2016 | $3,030,000 | +273.2% | 2,414,000 | +300.3% | 0.02% | +220.0% |
| Q4 2015 | $812,000 | -86.3% | 603,000 | -84.6% | 0.01% | -84.8% |
| Q1 2015 | $5,939,000 | +180.9% | 3,922,000 | +103.1% | 0.03% | +135.7% |
| Q3 2014 | $2,114,000 | +4597.8% | 1,931,000 | +4497.6% | 0.01% | – |
| Q4 2013 | $45,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |